NCT00666536

The Effects of Moderate vs. Aggressive Treatment With Valsartan + Amlodipine on Patients With Hypertension Uncontrolled by Angiotensin-Receptor Blocker (Herein, ARB) Monotherapy

A Multicenter, Randomized, Double Blind, Parallel Design Trial to Evaluate the Blood Pressure Lowering Efficacy Comparing Moderate Versus Aggressive Treatment Regimen of Valsartan + Amlodipine in Patients Uncontrolled on ARB Monotherapy

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 728 (actual)
• Sponsor: Novartis · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this trial is to compare blood pressure lowering efficacy of moderate Valsartan + Amlodipine treatment regimen (160 / 5 mg) with that of aggressive regimen (320 / 10 mg) in patients uncontrolled on ARB monotherapy, other than Valsartan

Conditions

• Hypertension

Interventions

Type	Name	Description
DRUG	valsartan and amlodipine
DRUG	valsartan and amlodipine

Timeline

• Start date: 2008-03-01
• Primary completion: 2009-01-01
• First posted: 2008-04-25
• Last updated: 2016-10-27
• Results posted: 2010-12-10

Locations

1 site across 1 country: United States